APA (7th ed.) Citation

Heidenreich, S., Egger-Heidrich, K., Halter, J. P., Jost, L., Stölzel, F., Perl, M., . . . Fante, M. A. (2025). Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation, 60(4), 439. https://doi.org/10.1038/s41409-024-02507-9

Chicago Style (17th ed.) Citation

Heidenreich, Silke, et al. "Safety and Efficacy of the ROCK-2-inhibitor Belumosudil in CGvHD Treatment - a Retrospective, German-Swiss Multicenter Real-world Data Analysis." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation 60, no. 4 (2025): 439. https://doi.org/10.1038/s41409-024-02507-9.

MLA (9th ed.) Citation

Heidenreich, Silke, et al. "Safety and Efficacy of the ROCK-2-inhibitor Belumosudil in CGvHD Treatment - a Retrospective, German-Swiss Multicenter Real-world Data Analysis." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation, vol. 60, no. 4, 2025, p. 439, https://doi.org/10.1038/s41409-024-02507-9.